Acute Myocardial Infarction in patients presenting with ST-segment elevation (Management of)

1.Preamble    
2.Introduction    
   2.1 Definition of acute myocardial infarction    
   2.2 Epidemiology of ST-segment elevation myocardial infarction    
3.What is new in the 2017 version?    
4.Emergency care    
   4.1 Initial diagnosis    
   4.2 Relief of pain, breathlessness, and anxiety    
   4.3 Cardiac arrest    
   4.4 Prehospital logistics of care   
5.Reperfusion therapy    
   5.1 Selection of reperfusion strategies    
   5.2 Primary percutaneous coronary intervention and adjunctive therapy      
   5.3 Fibrinolysis and pharmaco invasive strategy   
   5.4 Coronary artery bypass graft surgery    
6.Management during hospitalization and at discharge    
    6.1 Coronary care unit/intensive coronary care unit    
    6.2 Monitoring    
    6.3 Ambulation    
    6.4 Length of stay    
    6.5 Special patient subsets    
    6.6. Risk assessment   
7.Long-term therapies for ST-segment elevation myocardial infarction    
   7.1 Lifestyle interventions and risk factor control       
   7.2 Antithrombotic therapy    
   7.3 Beta-blockers   
   7.4 Lipid-lowering therapy    
   7.5 Nitrates    
   7.6 Calcium antagonists    
   7.7 Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers    
   7.8 Mineralocorticoid/aldosterone receptor antagonists    
8.Complications following ST-segment elevation myocardial infarction    
   8.1 Myocardial dysfunction     
   8.2 Heart failure   
   8.3 Management of arrhythmias and conduction disturbances in the acute phase   
   8.4 Mechanical complications      
   8.5 Pericarditis       
9.Myocardial infarction with non-obstructive coronary arteries (MINOCA)    
10.Assessment of quality of care    
11.Gaps in the evidence and areas for future research    
12.Key Messages   
13.Evidenced-based “To do and not to do” messages from the Guidelines    
14.Web addenda    
15.Appendix    
16.References